Fogo AB - Search Results

1

Hartle PM, Carlo ME, Dwyer JP, Fogo AB. Hartle PM, et al. Among authors: fogo ab. J Am Soc Nephrol. 2013 Jul;24(8):1204-8. doi: 10.1681/ASN.2012070665. Epub 2013 Apr 4. J Am Soc Nephrol. 2013. PMID: 23559580 Free PMC article.

2

Functional significance of leukotriene B4 in normal and glomerulonephritic kidneys.

Yared A, Albrightson-Winslow C, Griswold D, Takahashi K, Fogo A, Badr KF. Yared A, et al. J Am Soc Nephrol. 1991 Jul;2(1):45-56. doi: 10.1681/ASN.V2145. J Am Soc Nephrol. 1991. PMID: 1655093

3

Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality.

Yoshioka T, Ichikawa I, Fogo A. Yoshioka T, et al. J Am Soc Nephrol. 1991 Oct;2(4):902-12. doi: 10.1681/ASN.V24902. J Am Soc Nephrol. 1991. PMID: 1721553

4

Adenovirus infection of the kidney: mass formation in a patient with Hodgkin's disease.

Teague MW, Glick AD, Fogo AB. Teague MW, et al. Among authors: fogo ab. Am J Kidney Dis. 1991 Oct;18(4):499-502. doi: 10.1016/s0272-6386(12)80121-1. Am J Kidney Dis. 1991. PMID: 1928070

5

Endothelin A receptor mediates functional but not structural damage in chronic cyclosporine nephrotoxicity.

Hunley TE, Fogo A, Iwasaki S, Kon V. Hunley TE, et al. J Am Soc Nephrol. 1995 Mar;5(9):1718-23. doi: 10.1681/ASN.V591718. J Am Soc Nephrol. 1995. PMID: 7780063

6

Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1.

Ma LJ, Nakamura S, Aldigier JC, Rossini M, Yang H, Liang X, Nakamura I, Marcantoni C, Fogo AB. Ma LJ, et al. Among authors: fogo ab. J Am Soc Nephrol. 2005 Apr;16(4):966-76. doi: 10.1681/ASN.2004060492. Epub 2005 Feb 23. J Am Soc Nephrol. 2005. PMID: 15728787

7

Proteomic patterns and prediction of glomerulosclerosis and its mechanisms.

Xu BJ, Shyr Y, Liang X, Ma LJ, Donnert EM, Roberts JD, Zhang X, Kon V, Brown NJ, Caprioli RM, Fogo AB. Xu BJ, et al. Among authors: fogo ab. J Am Soc Nephrol. 2005 Oct;16(10):2967-75. doi: 10.1681/ASN.2005030262. Epub 2005 Aug 3. J Am Soc Nephrol. 2005. PMID: 16079267

8

Regression of existing glomerulosclerosis by inhibition of aldosterone.

Aldigier JC, Kanjanbuch T, Ma LJ, Brown NJ, Fogo AB. Aldigier JC, et al. Among authors: fogo ab. J Am Soc Nephrol. 2005 Nov;16(11):3306-14. doi: 10.1681/ASN.2004090804. Epub 2005 Sep 28. J Am Soc Nephrol. 2005. PMID: 16192423

9

Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.

Wang XP, Fogo AB, Colon S, Giannico G, Abul-Ezz SR, Miner JH, Borza DB. Wang XP, et al. Among authors: fogo ab. J Am Soc Nephrol. 2005 Dec;16(12):3563-71. doi: 10.1681/ASN.2005060670. Epub 2005 Oct 19. J Am Soc Nephrol. 2005. PMID: 16236801

10

Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction.

Suganuma E, Zuo Y, Ayabe N, Ma J, Babaev VR, Linton MF, Fazio S, Ichikawa I, Fogo AB, Kon V. Suganuma E, et al. Among authors: fogo ab. J Am Soc Nephrol. 2006 Feb;17(2):433-41. doi: 10.1681/ASN.2005080883. Epub 2005 Dec 21. J Am Soc Nephrol. 2006. PMID: 16371432

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

572 results

Search Page